Manuscripts and Publications

Filters: Author is Siegler, Aaron J  [Clear All Filters]
Publication
Steehler K, Siegler AJ.  2019.  Bringing HIV Self-Testing to Scale in the United States: a Review of Challenges, Potential Solutions, and Future Opportunities.. J Clin Microbiol. 57(11)
Siegler AJ, Brock JB, Hurt CB, Ahlschlager L, Dominguez K, Kelley CF, Jenness SM, Wilde G, Jameson SB, Bailey-Herring G et al..  2019.  An Electronic Pre-Exposure Prophylaxis Initiation and Maintenance Home Care System for Nonurban Young Men Who Have Sex With Men: Protocol for a Randomized Controlled Trial.. JMIR Res Protoc. 8(6):e13982.
Sullivan PS, Mena L, Elopre L, Siegler AJ.  2019.  Implementation Strategies to Increase PrEP Uptake in the South.. Curr HIV/AIDS Rep. 16(4):259-269.
Siegler AJ, Komro KA, Wagenaar AC.  2020.  Law Everywhere: A Causal Framework for Law and Infectious Disease.. Public Health Rep. 135(1_suppl):25S-31S.
Sullivan PS, Mouhanna F, Mera R, Pembleton E, Castel AD, Jaggi C, Jones J, Kramer MR, McGuinness P, McCallister S et al..  2020.  Methods for county-level estimation of pre-exposure prophylaxis coverage and application to the U.S. Ending the HIV Epidemic jurisdictions.. Ann Epidemiol. 44:16-30.
Siegler AJ, Knox J, Bauermeister JA, Golinkoff J, Hightow-Weidman L, Scott H.  2021.  Mobile app development in health research: pitfalls and solutions.. Mhealth. 7:32.
Siegler AJ.  2021.  Needed: A Life Course Perspective on Maintaining Pre-exposure Prophylaxis Use.. Clin Infect Dis. 72(3):386-387.
Coy KC, Hazen RJ, Kirkham HS, Delpino A, Siegler AJ.  2019.  Persistence on HIV preexposure prophylaxis medication over a 2-year period among a national sample of 7148 PrEP users, United States, 2015 to 2017.. J Int AIDS Soc. 22(2):e25252.
Siegler AJ, C Mehta C, Mouhanna F, Giler RMera, Castel A, Pembleton E, Jaggi C, Jones J, Kramer MR, McGuinness P et al..  2020.  Policy- and county-level associations with HIV pre-exposure prophylaxis use, the United States, 2018.. Ann Epidemiol. 45:24-31.e3.
Siegler AJ.  2020.  Preexposure Prophylaxis Indication Criteria Underidentify Black and Latinx Persons and Require Revision.. Am J Public Health. 110(3):267-268.
Hall CDXavier, Smith JC, Driggers RA, Stoller B, Khan Z, Li J, Ignatius EH, Siegler AJ.  2021.  PrEParing for long-acting injectable PrEP in the South: perspectives from healthcare providers in Georgia.. AIDS Care. 33(6):706-711.
Siegler AJ, Bratcher A, Weiss KM.  2020.  Siegler et al. Respond.. Am J Public Health. 110(1):e3-e4.
Siegler AJ, Wiatrek S, Mouhanna F, K Amico R, Dominguez K, Jones J, Patel RR, Mena LA, Mayer KH.  2020.  Validation of the HIV Pre-exposure Prophylaxis Stigma Scale: Performance of Likert and Semantic Differential Scale Versions.. AIDS Behav. 24(9):2637-2649.